您的位置: 首页 > 农业专利 > 详情页

CONSTRUCTIONS D'ANTICORPS BISPECIFIQUES DIRIGES CONTRE MUC17 ET CD3
专利权人:
AMGEN RESEARCH (MUNICH) GMBH;AMGEN INC.
发明人:
RAUM, TOBIAS,ARVEDSON, TARA,BAILIS, JULIE,DAHLHOFF, CHRISTOPH,ROSS, SANDRA,CHEN, IRWIN,BLUMEL, CLAUDIA,NAHRWOLD, ELISABETH,PENDZIALEK, JOCHEN,WAHI, JOACHIM
申请号:
CA3087151
公开号:
CA3087151A1
申请日:
2018.12.31
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The present invention provides bispecific antibody constructs characterized by comprising a first domain binding to MUC17, a second domain binding to an extracellular epitope of the human and the Macaca CD3e chain and optionally a third domain, which is a specific Fc modality. Moreover, the invention provides a polynucleotide, encoding the antibody construct, a vector comprising this polynucleotide, host cells, expressing the construct and a pharmaceutical composition comprising the same.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充